Treatment of EGFR inhibitor-induced acneiform rash
Treatment of EGFR inhibitor-induced acneiform rash
EGFR: epidermal growth factor receptor; CTCAE: Common Terminology Criteria for Adverse Events; SPF: sun protection factor; ADL: activities of daily living; PI: prescribing information.
* It is recommended that patients treated with EGFR inhibitors begin prophylactic rash therapy with doxycycline 100 mg twice a day or minocycline 100 mg daily and a low-potency topical steroid twice a day for the first 6 weeks of therapy.